Back to Search Start Over

Apolipoprotein E and Alzheimer's disease pathology in African American older adults.

Authors :
Royse SK
Snitz BE
Hill AV
Reese AC
Roush RE
Kamboh MI
Bertolet M
Saeed A
Lopresti BJ
Villemagne VL
Lopez OL
Reis SE
Becker JT
Cohen AD
Source :
Neurobiology of aging [Neurobiol Aging] 2024 Jul; Vol. 139, pp. 11-19. Date of Electronic Publication: 2024 Mar 30.
Publication Year :
2024

Abstract

The apolipoprotein-E4 (APOE*4) and apolipoprotein-E2 (APOE*2) alleles are more common in African American versus non-Hispanic white populations, but relationships of both alleles with Alzheimer's disease (AD) pathology among African American individuals are unclear. We measured APOE allele and β-amyloid (Aβ) and tau using blood samples and positron emission tomography (PET) images, respectively. Individual regression models tested associations of each APOE allele with Aβ or tau PET overall, stratified by racialized group, and with a racialized group interaction. We included 358 older adults (42% African American) with Aβ PET, 134 (29% African American) of whom had tau PET. APOE*4 was associated with higher Aβ in non-Hispanic white (P < 0.0001), but not African American (P = 0.64) participants; racialized group modified the association between APOE*4 and Aβ (P < 0.0001). There were no other racialized group differences. These results suggest that the association of APOE*4 and Aβ differs between African American and non-Hispanic white populations. Other drivers of AD pathology in African American populations should be identified as potential therapeutic targets.<br />Competing Interests: Declaration of Competing Interest None.<br /> (Copyright © 2024. Published by Elsevier Inc.)

Details

Language :
English
ISSN :
1558-1497
Volume :
139
Database :
MEDLINE
Journal :
Neurobiology of aging
Publication Type :
Academic Journal
Accession number :
38582070
Full Text :
https://doi.org/10.1016/j.neurobiolaging.2024.03.005